meliacin
antivir
principl
present
partial
purifi
leaf
extract
melia
azedarach
l
prevent
develop
herpet
stromal
kerat
hsk
mice
diminish
viral
load
eye
sever
lesion
caus
virusinduc
immunopatholog
reaction
tetranortriterpenoid
cdm
obtain
purif
display
antiherpet
activ
imped
nuclear
factor
b
nfb
activ
infect
conjunctiv
cell
extend
understand
cdm
biolog
properti
investig
activ
well
effect
nfb
activ
cytokin
secret
induc
viral
novir
lp
stimuli
corneal
cell
macrophag
cdm
exert
potent
effect
corneal
cell
inhibit
nfb
transloc
nucleu
lead
decreas
product
besid
cdm
seem
modul
respons
macrophag
whether
infect
stimul
lp
howev
cdm
affect
nfb
activ
cell
suggest
altern
nfb
cell
signal
pathway
would
involv
modul
cytokin
product
conclud
addit
antivir
effect
cdm
would
act
immunomodul
compound
would
respons
improv
murin
hsk
alreadi
report
great
varieti
ethnomedicin
plant
studi
sourc
natur
product
use
develop
novel
drug
establish
mani
inhibit
sever
step
viral
replic
cycl
mani
dna
andor
rna
virus
chattopadhyay
naik
report
meliacin
antivir
principl
present
partial
purifi
leaf
extract
melia
azedarach
l
exert
antivir
action
develop
herpet
stromal
kerat
hsk
mice
caus
signific
decreas
viral
load
eye
herp
simplex
viru
type
infect
anim
well
incid
sever
lesion
due
virusinduc
immunopatholog
reaction
et
al
bioassay
guid
purif
led
isol
limonoid
cdm
reduc
vesicular
stomat
viru
vsv
multipl
vero
cell
et
al
found
late
step
vsv
multipl
cycl
hinder
cdm
sinc
glycoprotein
g
b
gc
gd
well
gg
vsv
confin
golgi
apparatu
cdm
ad
infect
barquero
et
al
barquero
et
al
ocular
diseas
occur
result
primari
infect
corneal
epithelium
cell
like
macrophag
interven
clear
viru
infect
eye
develop
immunolog
driven
stromal
kerat
bauer
et
al
biswa
rous
besid
conjunctiv
cell
also
involv
amplifi
inflammatori
process
eye
kase
et
al
shown
activ
nuclear
factor
b
nfb
play
pivot
role
trigger
immun
inflammatori
respons
rang
stimuli
includ
viral
infect
human
cell
leukemia
viru
type
hepat
b
influenza
virus
report
induc
strong
nuclear
transloc
nfb
human
cell
line
see
front
matter
elsevi
bv
right
reserv
could
sever
function
promot
viral
replic
prevent
virusinduc
apoptosi
mediat
immun
respons
invad
pathogen
gregori
et
al
hiscott
et
al
great
number
plantderiv
substanc
sesquiterpen
diand
triterpen
prevent
nfb
activ
describ
nam
found
cdm
abl
block
induc
activ
nfb
inhibit
transloc
nucleu
infect
human
conjunctiv
cell
nhc
postul
cdm
would
abl
abolish
murin
hsk
control
viral
spread
associ
immunopatholog
well
barquero
et
al
aim
present
studi
determin
whether
cdm
display
antivir
activ
infect
corneal
cell
target
multipl
vivo
well
effect
transloc
nfb
nucleu
sinc
nfb
play
particularli
import
role
far
express
cytokin
concern
santoro
et
al
also
evalu
modul
effect
cdm
product
differ
cytokin
corneal
cell
macrophag
human
corneallimb
epitheli
hcle
cell
kindli
provid
dr
ilen
k
gipson
dr
pablo
schepen
eye
research
institut
harvard
medic
school
boston
usa
grown
gibco
keratinocyt
serum
free
medium
supplement
gml
bovin
pituitari
extract
bpe
ngml
epiderm
growth
factor
egf
mm
cacl
maintain
low
calcium
murin
macrophag
cell
line
kindli
provid
dr
osvaldo
zabal
intacastelar
bueno
air
grown
rpmi
medium
supplement
inactiv
fetal
bovin
serum
fb
rpmi
maintain
rpmi
supplement
inactiv
fb
rpmi
murin
cell
vero
cell
grown
eagl
minim
essenti
medium
supplement
inactiv
fb
mem
maintain
mem
supplement
inactiv
fb
mem
ko
strain
propag
low
multipl
use
vitro
experi
lp
e
coli
serotyp
obtain
sigma
rabbit
polyclon
antibodi
mous
monoclon
antibodi
antigd
obtain
santa
cruz
biotechnolog
usa
monoclon
anticalnexin
antibodi
obtain
chemicon
antiactin
merck
antibodi
kindli
provid
dr
viviana
castilla
laboratori
virolog
school
scienc
univers
bueno
air
secondari
goat
antirabbit
fluorolink
tm
cy
tm
antimous
fluorolink
tm
cy
tm
antibodi
purchas
ge
healthcar
bioscienc
argentina
peroxidaseconjug
goat
antirabbit
antimous
antibodi
obtain
icn
immunobiolog
cdm
purifi
leav
azedarach
l
describ
et
al
solubil
mem
final
concentr
mgml
mm
store
c
cell
viabil
presenc
compound
determin
use
cleavag
tetrazolium
salt
mtt
bromid
sigma
mitochondri
enzym
succin
dehydrogenas
give
blue
product
formazan
denizot
lang
hcle
cell
seed
concentr
cellswel
plate
grown
c
h
cultur
medium
replac
medium
contain
cdm
variou
concentr
triplic
cell
grown
h
ad
ml
mtt
mgml
distil
water
cell
cultur
medium
mtt
cleavag
h
c
formazan
product
solubil
addit
ml
ethanol
absorb
well
measur
eurogenet
mpra
micropl
reader
use
test
wavelength
nm
refer
wavelength
nm
result
express
percentag
absorb
treat
cell
cultur
respect
untreat
one
hcle
cell
grown
tissu
cultur
plate
infect
multipl
infect
moi
pfucel
h
adsorpt
c
inoculum
remov
medium
contain
differ
concentr
cdm
ad
triplic
plate
incub
c
co
atmospher
cell
death
observ
microscop
untreat
infect
control
cell
approxim
h
postinfect
pi
cell
disrupt
three
cycl
freez
thaw
supernat
harvest
pool
viru
yield
titrat
plaqu
assay
vero
cell
effect
concentr
ec
valu
calcul
concentr
cdm
requir
reduc
yield
infecti
viru
rel
untreat
viru
control
hcle
cell
grown
coverslip
treat
cdm
h
c
stain
acridin
orang
gml
min
c
cell
wash
twice
cold
pb
mount
pb
visual
olympu
epifluoresc
optic
subconflu
cell
grown
glass
coverslip
plate
fix
methanol
min
c
three
wash
pb
coverslip
invert
drop
dilut
primari
antibodi
min
c
return
cultur
dish
subject
three
addit
wash
pb
afterward
cell
incub
dilut
secondari
antibodi
min
c
final
coverslip
rins
mount
photograph
olympu
confoc
microscop
olympu
epifluoresc
optic
whole
extract
cell
grown
plate
h
load
sodium
dodecyl
sulphatepolyacrilamid
gel
electrophoresi
sdspage
transfer
onto
polyvinyliden
fluorid
pvdf
membran
min
membran
block
pb
contain
unfit
milk
overnight
incub
dilut
primari
antibodi
h
c
wash
membran
incub
dilut
peroxidaseconjug
antibodi
h
c
immunoreact
band
visual
use
enhanc
chemilumines
system
ecl
perkinelm
calnexin
actin
use
load
control
cell
frozen
thaw
supernat
harvest
centrifug
rpm
min
cytokin
quantifi
elisa
biolog
assay
triplic
human
mous
quantifi
commerci
elisa
set
bd
opteiatm
becton
dickinson
usa
accord
manufactur
instruct
measur
mous
bioactiv
perform
cellbas
bioassay
decker
et
al
minor
modif
cell
grown
cultur
plate
cellswel
h
c
supernat
remov
substitut
sampl
assay
content
success
twofold
dilut
incub
c
gml
actinomycin
acd
sidu
argentina
h
cell
fix
formaldehyd
stain
crystal
violet
assess
activ
light
absorb
nm
elut
crystal
violet
sampl
measur
compar
mous
recombin
standard
dilut
seri
sigma
bioassay
specif
sinc
activ
neutral
antibodi
student
ttest
use
statist
analysi
data
well
known
establish
infect
usual
epitheli
layer
cornea
deshpand
et
al
consid
cdm
suppress
replic
vero
human
conjunctiv
cell
decid
investig
effect
cdm
hcle
cell
multipli
reach
maximum
viral
titer
h
pi
et
al
barquero
et
al
hcle
cell
infect
treat
differ
concentr
cdm
dosedepend
inhibit
viral
yield
observ
ec
valu
calcul
besid
cdm
prove
cytotox
effect
concentr
test
fig
previous
report
cdm
display
antivir
action
affect
traffick
gb
gc
gd
vero
nhc
cell
suppli
infect
barquero
et
al
order
studi
effect
cdm
transport
viral
glycoprotein
corneal
cell
hcle
cell
infect
moi
treat
cdm
total
ifi
stain
perform
use
antigd
monoclon
antibodi
found
gd
exhibit
perinuclear
local
associ
golgi
apparatu
fig
alreadi
shown
inhibit
viral
glycoprotein
transport
may
relat
perturb
acid
ph
intracellular
organel
sidhu
et
al
although
mechan
cdm
affect
exocyt
pathway
still
unravel
shown
cdm
provok
basif
ph
endosom
vesicl
vero
cell
barquero
et
al
demonstr
cdm
also
modifi
endosom
ph
hcle
cell
vital
fluoresc
microscop
studi
reveal
untreat
cell
exhibit
bright
orang
punctat
fluoresc
concentr
lowph
vesicl
nevertheless
ph
acid
intracellular
vesicl
cdmtreat
cell
markedli
affect
sinc
faint
granular
fluoresc
observ
h
treatment
fig
summari
cdm
induc
hcle
cytoplasm
alkalin
exert
potent
effect
confin
glycoprotein
golgi
apparatu
previous
shown
cdm
block
induc
activ
nfb
inhibit
transloc
nucleu
conjunctiv
cell
barquero
et
al
henc
examin
effect
cdm
nfb
intracellular
local
infect
hcle
cell
moi
h
pi
cell
fix
process
ifi
stain
use
rabbit
polyclon
antibodi
visual
inspect
imag
observ
remain
cytoplasm
uninfect
cell
wherea
induc
nfb
transloc
nucleu
hcle
cell
qualit
observ
corrobor
calcul
percentag
transloc
number
cell
fluoresc
nucleu
rel
total
cell
number
cell
per
coverslip
nfb
nuclear
transloc
occur
major
infect
cell
wherea
viralinduc
nfb
activ
effici
impair
cdm
sinc
hcle
treatedinfect
cell
retain
nuclei
fig
togeth
nfb
also
detect
gd
marker
viral
infect
doubl
ifi
stain
found
nuclear
fluoresc
nuclei
infect
cell
associ
gd
express
hcle
infect
cell
treat
cdm
gd
detect
coincid
scatter
foci
infect
fig
thu
inhibit
nfb
transloc
treatedinfect
cell
could
ascrib
restraint
viral
propag
caus
cdm
rather
intrins
effect
nfb
sinc
transloc
nfb
nucleu
preced
proteolyt
degrad
inhibitor
cytoplasm
determin
whether
inhibit
nfb
activ
cdm
concomit
degrad
hcle
cell
infect
moi
treat
cdm
h
pi
cell
process
western
blot
analysi
use
rabbit
polyclon
anti
antibodi
found
almost
complet
degrad
infect
expect
addit
cdm
hamper
induc
persist
degrad
besid
observ
cdm
nt
induc
degrad
uninfect
cell
fig
alreadi
report
abl
activ
nfb
human
telomeraseimmort
corneal
epitheli
cell
hucl
concomit
transcript
express
among
cytokin
li
et
al
howev
hcle
cell
fail
produc
infect
michelini
et
al
assess
biolog
relev
inhibit
nfb
transloc
provok
cdm
cytokin
product
measur
effect
secret
supernat
harvest
hcle
cell
infect
moi
treat
cdm
use
quantifi
elisa
triplic
found
product
ten
fold
higher
uninfect
cell
p
increas
significantli
reduc
half
cdm
ad
infect
cell
p
uninfect
cell
signific
differ
releas
nontreat
cdmtreat
cell
detect
fig
taken
togeth
result
suggest
nfb
transloc
prevent
consequ
activ
cdm
would
lead
decreas
product
although
corneal
epitheli
cell
constitut
first
line
defenc
ocular
infect
macrophag
also
play
crucial
role
one
domin
cell
infiltr
infect
cornea
mott
et
al
thu
decid
evalu
effect
cdm
cell
infect
consequ
first
investig
antivir
action
cdm
find
inhibit
multipl
ec
valu
without
cytotox
effect
data
shown
describ
cell
line
similar
pattern
nfb
transloc
degrad
observ
cell
infect
gregori
et
al
mean
ifi
stain
found
fluoresc
remain
cytoplasm
uninfect
cell
wherea
induc
transloc
nucleu
infect
cell
correl
degrad
observ
immunoblot
assay
cdm
ad
percentag
cell
exhibit
nfb
transloc
nucleu
drop
expect
degrad
inhibit
cdmtreat
infect
cell
fig
b
well
establish
infect
trigger
proinflammatori
cytokin
product
macrophag
biswa
rous
melchjorsen
et
al
thu
investig
effect
cdm
secret
elisa
biolog
assay
respect
case
uninfect
cell
level
accumul
cultur
medium
h
vari
control
cdmtreat
cell
concentr
significantli
lower
supernat
cdmtreat
cell
respect
untreat
cell
p
yield
belong
cdmtreat
cell
much
higher
accumul
control
cell
p
fig
shown
fig
infect
induc
macrophag
secret
increas
amount
comparison
uninfect
cell
p
p
respect
howev
cdmtreat
cell
fail
produc
respons
infect
p
wherea
strong
enhanc
secret
observ
p
henc
cdm
seem
modul
respons
cytokin
cell
whether
infect
sinc
previous
shown
addit
increas
concentr
lpsstimul
mous
periton
macrophag
synerg
amount
releas
dosedepend
manner
use
lp
stimulu
instead
evalu
sole
immunomodul
effect
cdm
petrera
coto
cell
stimul
lp
gml
presenc
absenc
cdm
min
c
cell
stain
nfb
subunit
detect
observ
cdm
inhibit
lp
inducednfb
transloc
fig
besid
cdm
affect
kinet
degrad
induc
lp
cdm
alon
neither
activ
nfb
led
degrad
fig
b
take
account
cdm
affect
lpsinduc
nfb
transloc
import
determin
cdm
abl
affect
yield
cell
stimul
lp
h
releas
enhanc
significantli
p
p
respect
fig
nevertheless
cdm
consider
reduc
releas
p
strongli
enhanc
product
p
h
treatment
lpsstimul
cell
fig
cell
cdm
inhibit
nfb
activ
degrad
depend
fact
macrophag
induc
lp
infect
modul
product
regardless
stimuli
use
sinc
long
time
medicin
plant
use
treat
viral
infect
chemic
divers
structur
complex
lack
substanti
toxic
effect
broad
spectrum
antivir
activ
natur
product
make
ideal
candid
new
therapeut
mukhtar
et
al
fact
terpenoid
isol
medicin
plant
attract
attent
mani
exhibit
specif
antivir
effect
coronaviru
sarscov
vitro
wen
et
al
triterpenoid
limonoid
isol
meliacea
plant
prove
inhibit
rsv
multipl
chen
et
al
joycharat
et
al
manner
murin
model
hsvinduc
ocular
diseas
provid
valuabl
inform
relat
viral
immun
stage
hsk
previous
report
topic
administr
cornea
infect
mice
exert
therapeut
effect
reduc
viral
load
well
abolish
ocular
inflammatori
reaction
neovascular
display
addit
antivir
activ
eventu
immunomodulatori
effect
et
al
anoth
report
describ
chemic
natur
antivir
principl
cdm
mechan
action
vero
nhc
cell
infect
barquero
et
al
barquero
et
al
present
paper
shown
cdm
display
potent
antivir
effect
hcle
cell
fig
higher
comparison
obtain
vero
cell
et
al
import
replic
eye
occur
almost
exclus
corneal
epitheli
cell
biswa
rous
direct
activ
cdm
achiev
compound
suppli
infect
alreadi
demonstr
cdm
affect
gb
gc
gd
glycoprotein
exocyt
pathway
nhc
vero
cell
confin
golgi
complex
barquero
et
al
demonstr
cdm
also
affect
traffick
least
gd
glycoprotein
exert
analog
antivir
effect
hcle
cell
fig
furthermor
hindranc
multipl
cdm
respons
inhibit
nfb
transloc
corneal
cell
fig
taken
togeth
result
would
explain
reduct
viru
yield
eye
matreat
infect
mice
et
al
recent
past
number
studi
explor
immunomodulatori
properti
plant
extract
antivir
properti
mukhtar
et
al
methanol
extract
cappari
spinosa
l
bud
upregul
express
proinflammatori
cytokin
besid
antihsv
activ
arena
et
al
likewis
pure
compound
plantago
genu
enhanc
activ
lymphocyt
prolifer
secret
chiang
et
al
develop
murin
hsk
involv
product
proinflammatori
cytokin
chemokin
neovascular
take
place
day
infect
viru
clear
eye
interestingli
prevent
ocular
diseas
infect
mice
administ
day
pi
onward
suggest
presenc
compound
immunomodul
activ
et
al
sens
found
cdm
modul
cytokin
product
vitro
fig
numer
cytokin
known
upregul
follow
ocular
infect
biswa
rous
signific
reduct
secret
detect
supernat
cdm
treatedinfect
epitheli
cell
macrophag
would
relat
inhibit
nfb
transloc
cdm
result
antivir
activ
fig
contrari
strong
increas
secret
cdmtreat
infect
cell
observ
absenc
nfb
activ
fig
would
exert
altern
nfb
cell
signal
pathway
activ
distinct
mitogenactiv
protein
map
kinas
cascad
diao
et
al
zacho
et
al
possibl
might
support
fact
cdm
enhanc
level
product
decreas
secret
imped
nfb
transloc
cell
induc
lp
rather
infect
fig
demonstr
cytokin
play
differ
role
corneal
angiogenesi
induc
product
vascular
endotheli
growth
factor
vegf
may
counter
induct
effect
vegf
vascular
endotheli
cell
result
blockad
neovascular
injur
cornea
vivo
biswa
et
al
fujita
et
al
case
would
argu
strong
increas
secret
togeth
reduct
due
cdm
could
respons
inhibit
neovascular
regist
mice
infect
cornea
treat
hypothes
improv
hsk
report
may
consequ
antivir
immunomodul
effect
observ
vitro
cdm
studi
antiangiogen
immunomodul
effect
cdm
need
deciph
mechan
action
sinc
avail
compound
gather
togeth
biolog
properti
make
viabl
candid
new
novel
antihsv
agent
